Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? "Reasons That Reason Itself Does Not Know…"

Braz J Cardiovasc Surg. 2021 Jun 1;36(3):I-II. doi: 10.21470/1678-9741-2021-0957.

Authors

Paulo Roberto B Evora¹, Walter J Gomes²

Affiliations

¹ Department of Surgery and Anatomy Ribeirão Preto School of Medicine. Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRPUSP), Ribeirão Preto, SP, Brazil.
² Cardiovascular Surgery Discipline and São Paulo Hospital. Escola Paulista de Medicina. Federal University of São Paulo, São Paulo, Brazil.

No abstract available

Publication types

Editorial

MeSH terms

Cardiopulmonary Bypass
Humans
Methylene Blue* / therapeutic use
Shock* / drug therapy

Substances

Methylene Blue